Perimeter Medical Imaging AI to Host Investor Webcast on June 25
Perimeter Medical Imaging AI will host an investor webcast on June 25, 2024, at 2:00 PM ET. The event will feature presentations from CEO Adrian Mendes, CIO Andrew Berkeley, and CFO Sara Brien, focusing on key business areas. Investors can engage in a live Q&A session. To participate, pre-register at the provided link. An archived version will be accessible on the company's website.
- None.
- The press release lacks concrete financial data or business developments.
- No new product announcements or significant business changes are mentioned.
- The webcast announcement alone does not provide substantial information impacting stock performance.
During the webcast, Adrian Mendes, CEO, Andrew Berkeley, CIO and Sara Brien, CFO, will conduct a presentation that will cover key areas of Perimeter's business. After the formal presentation, investors will have an opportunity to ask relevant questions through an interactive Q&A portal. To listen to the webcast or to ask questions during the live event, please pre-register at the following link:
https://us02web.zoom.us/webinar/register/WN_u8RVMf9_Qaik3JmCOKKTPw
An archived version of the webcast and presentation will be available on the Company's website: https://ir.perimetermed.com/news-events/ir-calendar
About Perimeter Medical Imaging AI, Inc.
Based in
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT, the expected benefits of Perimeter's updated version of its ImgAssist AI, the expected timing of the completion of full enrollment in Perimeter's clinical trial, Perimeter's expectations regarding the outcomes of the clinical trial, and the timing of Perimeter's webcast investor presentation, are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2023, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
View original content:https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-to-host-investor-webcast-on-june-25-302176380.html
SOURCE Perimeter Medical Imaging AI Inc.
FAQ
When is Perimeter Medical Imaging AI's investor webcast?
Who will present at Perimeter Medical Imaging AI's investor webcast?
How can I participate in Perimeter Medical Imaging AI's investor webcast?
Where can I find the archived version of Perimeter Medical Imaging AI's webcast?
What topics will be covered in Perimeter Medical Imaging AI's investor webcast?
